Boule Diagnostics AB (BOUL) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Boule Diagnostics Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.077 -- 00:00:05.942 Good morning, everybody, and welcome to the second quarter earnings call for Bull Diagnostics. 00:00:05.942 -- 00:00:11.248 I'm Holger Lemberg, CFO for Bull Diagnostics, and with me, I have our CEO, Torben Nielsen. 00:00:11.248 -- 00:00:14.231 After our presentation, we will open up for questions. 00:00:14.231 -- 00:00:17.715 Please also feel free to type questions in the chat field. 00:00:17.715 -- 00:00:20.956 With that, I'm handing over to you, Torben. 00:00:21.299 -- 00:00:26.604 Thank you, Holger, and good morning, and welcome to all of you joining this Q2 00:00:26.604 -- 00:00:32.709 earnings call. Let's begin by looking at the highlights of the quarter. 00:00:32.709 -- 00:00:37.994 The second quarter of the year saw the continued effects of the geopolitical instability 00:00:37.994 -- 00:00:42.078 with longer than usual supply chain lead times, 00:00:42.078 -- 00:00:46.903 delayed payments from key customers due to continuing bank restrictions 00:00:46.903 -- 00:00:52.327 and unfavorable effects development from a weakening US dollar. 00:00:52.469 -- 00:00:57.018 CO2 was overall and relatively speaking a stable quarter. 00:00:57.018 -- 00:01:02.303 with a 3.3% organic decline compared to last year. 00:01:02.303 -- 00:01:07.488 Instrument unit sales grew 17% year over year, however, at a lower average 00:01:07.488 -- 00:01:09.310 selling price. 00:01:09.310 -- 00:01:14.715 This is part of our strategic focus to grow our install base as a way of investing 00:01:14.715 -- 00:01:18.257 in future reagent business growth. 00:01:18.880 -- 00:01:24.288 Our five pound instrument sales more than doubled in both the quarter and year to date. 00:01:24.288 -- 00:01:29.672 reflecting the higher demand for five-part technology in the marke...